Get started
Author

Heba Ibrahim Abdallah

448P Real-world experience with CDK4/6 inhibitors for HR+/HER2-metastatic breast cancer (MBC)
2023 · H.M.A. Abdallah, Y.I. Owoseni, et al. · Annals of Oncology · 7
The Saudi experience with neutron therapy in locally advanced head and neck cancers
1996 · A.D. Flores, A. Kandil, et al. · Bulletin du Cancer/Radiothérapie · 4
External factors affecting weight loss during intermittent fasting. Author's reply
2024 · M. Khalil, H. Abdallah, et al. · European Journal of Internal Medicine · 1
800P Response to chemotherapy following PARP inhibition in UK ovarian cancer (OC) patients
2023 · S. Howlett, A.M. Berner, et al. · Annals of Oncology · 1
PDF
Cost Effectiveness Analysis of Exemestane Versus Capecitabine Monotherapy for Patients with Hormone Receptor–Positive and Her2-Negative, Metastatic Breast Cancer from National Cancer Institute Prespective in Egypt
2017 · H Abdallah, AS Abourawash, et al. · Value in Health · 1
PDF
Evaluating transforming growth factor-B and interleukin-6 as a prognostic markers in pediatric critically ill septic patients
2025 · Ayman Emil Eskander, Hanaa Ibrahim Rady, et al. · Egyptian Pediatric Association Gazette
PDF
Soluble Urokinase Plasminogen Activator Receptor in Full–Term Neonates with Sepsis: Relation to Disease Severity and Clinical Outcome
2025 · Dina Mohamed Shinkar, Eman Abdel Rahman Ismail, et al. · Journal of Neonatology
T.12.8: Effects of Ramadan Intermittent Fasting on Gastrointestinal Motility and Gastrointestinal Symptoms in Healthy Subjects
2024 · H. Abdallah, M. Khalil, et al. · Digestive and Liver Disease
Predicting Dosimetry of Stereotactic Ablative Radiotherapy for the Treatment of Multiple Lung Lesions
2023 · E. Wang, H. Abdallah, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Works count: 9
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type